PP
CYTR

Paloma Partners’s CytRx Corp CYTR Stock Holding History

Paloma Partners’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-72,108
Closed -$271K – 2704
2017
Q2 		$271K Buy
+72,108
New +$246K ﹤0.01% 1848
2014
Q4 		– Sell
-6,471
Closed -$99K – 1582
2014
Q3 		$99K Buy
+6,471
New +$128K ﹤0.01% 897

Other funds holding CYTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paloma Partners's CYTR Position: Q3 2017 in Review

Paloma Partners sold out of CytRx Corp (CYTR) in Q3 2017, closing a stake of 72,108 shares — an estimated $271K sold.

Paloma Partners first reported a position in CYTR in Q3 2014 and held it in 2 quarters. The position peaked at $271K in Q2 2017. 47 funds tracked by Wall St. Rank hold CYTR as of Q3 2017.

  • Paloma Partners reported no remaining CytRx Corp position as of Q3 2017 after selling out during the quarter.
  • Paloma Partners sold 72,108 CytRx Corp shares in Q3 2017, an estimated $271K.
  • Paloma Partners first reported a position in CytRx Corp in Q3 2014 and held it in 2 quarters.
  • Paloma Partners's CytRx Corp position peaked at $271K in Q2 2017.
  • 47 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2017.

Based on Paloma Partners's 13F filing for Q3 2017, filed 14 Nov 2017.